Galectin Therapeutics Inc. (GALT)
NASDAQ·Healthcare·Biotechnology
$2.34
-1.48%
Mkt Cap $215.98M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+371.1%
Consensus $11.00 vs current $2.34
NASDAQ·Healthcare·Biotechnology
$2.34
-1.48%
Mkt Cap $215.98M
No recent rating data.
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+371.1%
Consensus $11.00 vs current $2.34